KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Return on Equity (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Return on Equity for 17 consecutive years, with 0.13% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 24.0% to 0.13% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.13% through Dec 2025, down 24.0% year-over-year, with the annual reading at 0.13% for FY2025, 54.0% down from the prior year.
  • Return on Equity hit 0.13% in Q4 2025 for Abbott Laboratories, down from 0.63% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 32.29% in Q4 2021 to a low of 8.09% in Q3 2023.
  • Historically, Return on Equity has averaged 2.05% across 5 years, with a median of 0.25% in 2024.
  • Biggest five-year swings in Return on Equity: surged 3229bps in 2021 and later tumbled -3406bps in 2022.
  • Year by year, Return on Equity stood at 32.29% in 2021, then crashed by -105bps to 1.77% in 2022, then soared by 31bps to 1.22% in 2023, then soared by 130bps to 0.37% in 2024, then plummeted by -66bps to 0.13% in 2025.
  • Business Quant data shows Return on Equity for ABT at 0.13% in Q4 2025, 0.63% in Q3 2025, and 2.0% in Q2 2025.